Abstract
In DISCHARGE-1, a recent Phase III diagnostic trial in aneurysmal subarachnoid haemorrhage patients, spreading depolarization variables were found to be an independent real-time biomarker of delayed cerebral ischaemia. We here investigated based on prospectively collected data from DISCHARGE-1 whether delayed infarcts in the anterior, middle, or posterior cerebral artery territories correlate with (i) extravascular blood volumes; (ii) predefined spreading depolarization variables, or proximal vasospasm assessed by either (iii) digital subtraction angiography or (iv) transcranial Doppler-sonography; and whether spreading depolarizations and/or vasospasm are mediators between extravascular blood and delayed infarcts. Relationships between variable groups were analysed using Spearman correlations in 136 patients. Thereafter, principal component analyses were performed for each variable group. Obtained components were included in path models with a priori defined structure. In the first path model, we only included spreading depolarization variables, as our primary interest was to investigate spreading depolarizations. Standardised path coefficients were 0.22 for the path from extravascular bloodcomponent to depolarizationcomponent (P = 0.010); and 0.44 for the path from depolarizationcomponent to the first principal component of delayed infarct volume (P < 0.001); but only 0.07 for the direct path from bloodcomponent to delayed infarctcomponent (P = 0.36). Thus, the role of spreading depolarizations as a mediator between blood and delayed infarcts was confirmed. In the principal component analysis of extravascular blood volume, intraventricular haemorrhage was not represented in the first component. Therefore, based on the correlation analyses, we also constructed another path model with bloodcomponent without intraventricular haemorrhage as first and intraventricular haemorrhage as second extrinsic variable. We found two paths, one from (subarachnoid) bloodcomponent to delayed infarctcomponent with depolarizationcomponent as mediator (path coefficients from bloodcomponent to depolarizationcomponent = 0.23, P = 0.03; path coefficients from depolarizationcomponent to delayed infarctcomponent = 0.29, P = 0.002), and one from intraventricular haemorrhage to delayed infarctcomponent with angiographic vasospasmcomponent as mediator variable (path coefficients from intraventricular haemorrhage to vasospasmcomponent = 0.24, P = 0.03; path coefficients from vasospasmcomponent to delayed infarctcomponent = 0.35, P < 0.001). Human autopsy studies shaped the hypothesis that blood clots on the cortex surface suffice to cause delayed infarcts beneath the clots. Experimentally, clot-released factors induce cortical spreading depolarizations that trigger (i) neuronal cytotoxic oedema and (ii) spreading ischaemia. The statistical mediator role of spreading depolarization variables between subarachnoid blood volume and delayed infarct volume supports this pathogenetic concept. We did not find that angiographic vasospasm triggers spreading depolarizations, but angiographic vasospasm contributed to delayed infarct volume. This could possibly result from enhancement of spreading depolarization-induced spreading ischaemia by reduced upstream blood supply.
Keywords: cytotoxic oedema, spreading depolarization, spreading ischaemia, subarachnoid haemorrhage, vasospasm
Horst et al. report that spreading depolarization variables are a statistical mediator between subarachnoid blood volume in initial computed tomography and delayed infarct volume in longitudinal neuroimaging after subarachnoid haemorrhage, whereas angiographic vasospasm is a mediator between intraventricular haemorrhage and delayed infarct volume and that the two do not correlate
Graphical Abstract
Introduction
Subarachnoid haemorrhage (SAH) is the second most common type of haemorrhagic stroke.1,2 In 85%, SAH is caused by the rupture of an aneurysm. Although SAH accounts for only ∼3% of all strokes and ∼5% of deaths from stroke, the relative youth of the affected individuals means that it is responsible for a quarter of all stroke-related years of potential life lost before age 65.3 In Depolarisations in ISCHaemia after subARachnoid haemorrhaGE-1 (DISCHARGE-1), a recent prospective, observational, multicentre, cohort, Phase III diagnostic trial of 180 patients with severe aneurysmal SAH (aSAH), the strongest predictor of long-term outcome was total focal brain damage detected by neuroimaging two weeks after the initial haemorrhage.4 Most prominent aetiologies of focal brain damage associated with aSAH are intracerebral haemorrhage (ICH), and infarction due to either early (ECI), or delayed cerebral ischaemia (DCI). DISCHARGE-1 found that the average patient admitted to the neurocritical care unit after aneurysm treatment had already lost 46 ± 73 ml (mean ± standard deviation) of brain tissue due to ICH and ECI and lost an additional 36 ± 80 ml (44% of the total focal brain damage) over the next two weeks because of delayed ischaemic infarcts. This tissue could be saved if we knew effective treatments, because DCI is a potentially modifiable aetiology of focal brain damage during neurocritical care, as it allows treatment with a neuroprotective intervention before the potential insult or soon after. The risk of DCI is particularly high after severe aSAH. Thus, delayed infarct volume in DISCHARGE-1 was significantly higher in deeply comatose patients than in patients who were at least transiently clinically assessable (48 ± 92 ml versus 23 ± 74 ml, P < 0.001).4 Severe cases require mechanical ventilation and sedation more often, which limits neurological assessment. Therefore, in the high-risk population, it is particularly difficult to identify and treat those patients who suffer from the complication. However, neurosurgical procedures are indicated early after aSAH, allowing implantation of invasive probes. This enables recording of the entire period of ischaemic stroke development, early treatment stratification according to changes in diagnostic summary measures recorded by neuromonitoring devices in real time and then re-assessment of these measures after neuroprotective interventions.5 In awake patients, neurologic examination might be the strongest DCI predictor.6 However, particularly in comatose or sleeping patients, the results of DISCHARGE-1 suggest that spreading depolarization (SD) variables are currently the most promising DCI predictor.4
SD is a phenomenon of the brain grey matter. Using subdural electrocorticography (ECoG), it is observed as a large negative direct current (DC) shift which spreads between adjacent recording sites (frequency band: < 0.05 Hz). SD is characterised by abrupt, near-complete breakdown of the transmembrane neuronal ion gradients with entropy increase, release of 90% of Gibbs free energy normally contained in the ion gradients, neuronal water uptake, soma swelling, dendritic beading, and MRI diffusion restriction.7-9 Collectively, SD is the prime process that initiates and maintains neuronal cytotoxic oedema in grey matter.9,10 This means that SD initiates toxic changes that eventually lead to neuronal death, but is not a marker of death per se, as it is reversible—up to a point—with restoration of the physiological state of low entropy by Na+/K + -ATPase (NaKA) activation.11 The most important NaKA activators in this context are the extreme increases in cytoplasmic Na+ and extracellular K+ concentration, which are nowhere near as high in any other grey matter pathological phenomenon as in SD.11-15 However, if NaKAs cannot be sufficiently activated, e.g. due to enzyme inhibition or as a result of ATP deficiency, the neurons die, which is indicated by the transition to a negative ultraslow potential (NUP) in ECoG and a persistent diffusion restriction in MRI.8,16-18
Importantly, SDs induce tone alterations in resistance vessels, causing either predominant hyperperfusion followed by a mild oligaemia (physiological haemodynamic response) in healthy tissue19,20; or severe and prolonged initial hypoperfusion (inverse haemodynamic response = spreading ischaemia) where the neurovascular unit is severely disturbed.5,21,22 SD in naive tissue associated with a normal haemodynamic response does not cause neuronal damage.23 However, SD-induced spreading ischaemia can lead to infarction even in brain tissue that was not yet ischaemic at the onset of SD.24 This is because spreading ischaemia-induced ATP deficiency keeps the neurons in the SD/cytotoxic oedema state, the SD/cytotoxic oedema state maintains vasoconstriction and the vasoconstriction restricts the substrate supply for ATP production.5 If this vicious circle is not interrupted, it eventually leads to ischaemic necrosis.5,21 Spreading ischaemia is thus distinguished from primary ischaemia, such as occurs in the setting of embolic or thrombotic occlusion of a major cerebral artery or cardiocirculatory arrest. Whereas in the case of spreading ischaemia, SD occurs first and is followed by ischaemia with a latency of several seconds, and both SD and ischaemia propagate in the tissue,5,21 in the case of severe primary ischaemia, ischaemia occurs first, followed by SD with a substantial latency of ∼1–5 minutes, and only SD, but not ischaemia, propagates in the tissue.16 Nevertheless, the process of spreading ischaemia can also build up on incomplete primary ischaemia.25-29 If primary ischaemia of the cortex does not lead to at least one SD, infarction does not occur.16,30-32 If primary ischaemia leads to SD but timely reperfusion occurs, no lesion develops either.16,33
The main principles of the SD process known from animal experiments could be verified in experiments with human brain slices.34-40 The entire SD continuum from short duration, to intermediate duration, to terminal waves has now been demonstrated in aSAH patients.4,41,42 After aSAH, SDs have been recorded in association with (i) migraine aura43; (ii) transitory ischaemic attacks4; (iii) status epilepticus36,44,45; (iv) vasogenic oedema development without infarction4; (v) ICH46; (vi) early ischaemic infarcts4,47,48; (vii) delayed ischaemic infarcts4,22,49; (viii) brain death development4,50,51 and (ix) dying from cardiocirculatory arrest.4,52 The broad range of conditions under which SD has been detected in patients using ECoG closely matches the wide range of conditions under which cytotoxic oedema is detected using neuroimaging. Importantly, however, this does not mean that every SD has a correlate on clinical MRI, as SD/neuronal cytotoxic oedema is usually initially reversible and once regressed is no longer detectable on neuroimaging.53,54 In addition, SD-induced spreading ischaemia and transition from clustered SDs to NUP were demonstrated in a small population of aSAH patients in whom optoelectrodes for laser-Doppler flowmetry and ECoG were located directly over newly developing delayed infarcts proven by longitudinal neuroimaging.4,16,17
SD is associated with different changes in spontaneous brain activity in the alternating current (AC) band of the ECoG (>0.5 Hz). These are non-spreading activity depression, spreading activity depression and epileptiform activity.11,36,52 The same SD wave may be associated with different activity changes and different haemodynamic responses in adjacent brain regions. In DISCHARGE-1, for each recording day of each patient, we determined (i) the total (cumulative) SD-induced depression duration (TDDD) and (ii) the number of SDs as the most important ECoG variables. While the a priori defined 60-min cut-off of TDDD indicated a reversible delayed neurological deficit, only a 180-min cut-off indicated new infarction with >0.60 sensitivity and >0.80 specificity.4 On this basis, it was recommended that rescue treatment be initiated at the 60-min cut-off rather than at the 180-min cut-off if progression of injury to infarction is to be prevented. Overall, SD variables were included in each multiple regression model for early, delayed and total brain damage, 7-month outcome, and death, suggesting that they are an independent biomarker of progressive brain injury.4
Traditional pathology literature describes delayed infarcts after aSAH as focal anaemic necroses, suggesting arterial/arteriolar spasm as underlying aetiology and ruling out mechanisms such as thrombotic occlusion, endothelial swelling, or venous compression.55 SD-induced vasocontraction, the cause of spreading ischaemia, is in fact the most extreme form of vasospasm in the brain currently known.5,21,22,24 In addition, two slowly evolving forms of vasospasm emerge after aSAH: angiographic (proximal) vasospasm and chronic constriction of distal arteries/arterioles.56-58 In the autopsy studies, the predominant lesion pattern consisted of widespread infarcts in the cerebral cortex.55,59-63 Seventy to 80% of patients showed such cortical infarcts in the large autopsy series.55,59 In particular, Stoltenburg-Didinger and Schwarz55 noted that these lesions typically develop beneath subarachnoid clots. In animal experiments, haemolysis products in the subarachnoid space without the simultaneous presence of proximal vasospam are sufficient to cause SD, SD-induced spreading ischaemia and cortical infarction.13,21,24,42,64,65 However, upstream restriction of regional cerebral blood flow (rCBF), if severe enough, can also trigger SDs66-69 and shift the normal, predominantly hyperaemic response to SD towards an inverse ischaemic response.25-27,70,71 Accordingly, there are two alternative hypotheses for the development of delayed SDs after aSAH: (i) blood degradation products around the basal conductive arteries trigger angiographic vasospasm, which acts as a mediator of SDs through a mismatch between supply and demand; or (ii) blood degradation products located on the cortex trigger SDs directly in the underlying cortex through other mechanisms, including neuronal, astrocytic and microvascular disruption and/or local inflammation. To test these two hypotheses, we here investigated based on prospectively collected data from DISCHARGE-1 whether delayed infarcts in the anterior (ACA), middle (MCA) or posterior cerebral artery (PCA) territories ipsilateral to the subdural electrodes correlate with (i) extravascular blood volumes in different compartments; (ii) predefined SD variables, or proximal vasospasm assessed by either (iii) digital subtraction angiography (DSA) or (iv) transcranial Doppler-sonography (TCD); and whether proximal vasospasm and/or SD variables are mediators between extravascular blood volumes and delayed infarcts.
Materials and methods
Study design and protocol
This study was designed and performed as a substudy of the Depolarisations in ISCHaemia after subARachnoid haemorrhaGE-1 (DISCHARGE-1) trial.4 As reported previously, patients with aSAH were screened for study inclusion and were consecutively enrolled in DISCHARGE-1 at six university-hospitals (Campus Benjamin Franklin and Campus Virchow Klinikum, Charité—Universitätsmedizin Berlin; University of Bonn; Goethe-University Frankfurt; University of Cologne and University Hospital Heidelberg) between September 2009 and April 2018.4 The protocol was approved by the local ethics committees. Either informed consent or surrogate informed consent was obtained. Research was conducted in accordance with the Declaration of Helsinki. Results were reported following the STROBE guidelines (https://www.strobe-statement.org). DISCHARGE-1 was preregistered (http://www.isrctn.com/ISRCTN05667702). If the patient was eligible, a subdural electrode strip (Wyler, Ad-Tech Medical, Racine, WI, USA) for SD monitoring was placed over vital cortex.
In DISCHARGE-1, 180 of 205 (87.8%) patients could be analysed. For the present substudy, 44 additional patients were excluded because (i) the preoperative CT was missing (n = 18); (ii) the CT slice thickness was <3 mm or >6 mm (n = 3); (iii) the patient died early before the occurrence of delayed infarction could be assessed (n = 10); (iv) the patient experienced a periprocedural postoperative haemorrhage with a volume >10 ml (n = 8); (v) the first postoperative neuroimage showed malignant early brain injury (n = 2) or (vi) an interventional complication occurred such as infarction due to clip stenosis (n = 3). Placement of the electrode strip was performed either directly after surgical treatment of the aneurysm via craniotomy (n = 120) or, in coiled patients, after burr hole trepanation simultaneously with the placement of a ventricular drain or oxygen sensor (n = 16). All evaluators were blinded to other measures.
The study design of DISCHARGE-1 has been previously described in great detail.4Figure 1A shows the study flow. In brief, neuroimaging included the pre-interventional CT to establish the diagnosis of aSAH and the post-interventional CT to locate the subdural ECoG electrodes. For the present substudy, early ischaemic cerebral infarcts were assessed using either a post-interventional MRI (n = 118) or CT (n = 18) performed no later than Day 5. The median day of this neuroimage, referred to as Imageearly, was Day 2 [interquartile range (IQR): 1–3]. Delayed ischaemic infarcts were assessed using a follow-up Imagelate (MRI: n = 120, CT: n = 16) on Day 14 (IQR: 13–15) in comparison to Imageearly. Recording, analysis and interpretation of SDs followed the published recommendations of the Co-Operative Studies on Brain Injury Depolarisations (COSBID) group.72 Importantly, in every patient, the first 24-h period after the initial haemorrhage was always denoted as ‘Day 0’, the second 24-h period as ‘Day 1’ and so on. Using LabChart-8 software (ADInstruments, Bella Vista, New South Wales, Australia), M.K.L.W. and C.L.L. determined the following for each recording day of each patient: (i) total (cumulative) SD-induced depression duration (TDDD); (ii) number of SDs; (iii) number of SDs in electrically inactive tissue (isoelectric SDs)72,73 and (iv) number of clustered SDs, i.e. SDs that occurred less than 1 h apart from the previous SD. For the present substudy, we used peak values of a recording day for each SD-variable resulting in (i) PTDDDdelayed; (ii) peak number of SDs of any type (peakSD-delayed); (iii) peak number of isoelectric SDs (peakisoSD-delayed) and (iv) peak number of clustered SDs (peakclusSD-delayed) for the delayed period between Imageearly and Imagelate after the end of neuromonitoring. TCD to determine mean blood flow velocities (mbfv) of the ACA (788 measurements), MCA (1060 measurements) and PCA (606 measurements) ipsilateral to the subdural electrodes was performed daily (n = 128). On this basis, peak values were determined for each of the three arteries and each patient. V.K. determined vascular narrowing using a qualitative grading score (no vascular narrowing = 1, vascular narrowing by 11–33% = 2, vascular narrowing by 34–66% = 3, vascular narrowing >67% = 4) for all DSAs performed between Days 5 and 17 [median Day 7 (IQR: 7–8), n = 106].4 The assessment included the first and second segments of MCA, ACA and PCA ipsilateral to the subdural electrodes (see also DSA grading score in the Supplementary material and Supplementary Fig. 1).
Delayed cerebral infarcts
We adopted parenchymal lesion volumes derived from manual segmentation in DISCHARGE-1.4 For the present substudy, we only used delayed ischaemic infarct volumes in the cerebral hemisphere ipsilateral to the subdural electrodes. Following Weidauer et al.,74 the volumes of ipsilateral delayed infarction were further segmented into five categories: cortical ACA infarction, cortical MCA infarction, cortical PCA infarction, cortical watershed infarction and deep infarction. The latter included perforator infarcts, singular white matter infarcts without cortical involvement and anterior choroidal artery infarcts. Ischaemic tissue adjacent to the aneurysm was excluded. The location of delayed infarcts was determined according to arterial territory maps specified by Tatu et al.75
Haemorrhage volumes
V.H. used the pre-interventional CT performed on median Day 0 (IQR: 0–0, range: 0–3) for volumetric haemorrhage quantification of the hemisphere ipsilateral to the subdural electrodes. Epidural, subdural, contralateral and infratentorial haemorrhages were not considered. Manual segmentation was carried out on non-contrast-enhanced images with a slice thickness between 3 and 6 mm using the paintbrush mode of ITK-Snap, Version 3.8.0 (www.itksnap.org). Ipsilateral haemorrhage was segmented into six predefined regions: subarachnoid blood accumulations on (i) the cerebral convexity (bloodconvex); (ii) in the interhemispheric fissure (bloodinter); (iii) Sylvian fissure (bloodSylvian), or (iv) basal cisterns (bloodbasal); (v) ICH, or (vi) intraventricular haemorrhage (IVH) (see Fig. 1B and C). According to van der Zande et al.,76 we differentiated bloodSylvian from ICH using CT angiography. Contrast-enhancing arteries within a haematoma indicated bloodSylvian, whereas a haematoma without visible contrast-enhancing vessels indicated ICH.
Statistical analysis
The statistical analysis was performed by P.M., the trial statistician of DISCHARGE-1. Unless otherwise stated, data are given as median (IQR). Relationships between the variable groups related to blood volume, SD, DSA, TCD-determined peak mbfvs and delayed infarct volumes were analysed bivariately using Spearman correlations. Correlations with uncorrected P-values <0.05 were discussed. However, for each group of comparisons it was noted which correlations remained significant after Bonferroni correction. In the next step, principal component analyses were performed for each of the variable groups, and only the first principal component was used in further analyses. In principal component analyses, log transformations were applied for blood volume variables, SD variables, DSA variables and delayed infarct volumes, but not for TCD-determined peak mbfvs. The obtained components were included in path models with a priori defined structure, treating blood volume variables as extrinsic variables, SD variables, DSA variables and TCD-determined peak mbfvs as potential mediator variables but also possibly extrinsic variables, and infarct volumes due to DCI as outcome. Analyses were performed using SPSS for Windows release 26. The path models were calculated using Amos release 26.
Data availability
Electronic recording, processing and storage of the data were approved by the data protection officer of the Charité—Universitätsmedizin Berlin (data protection votes from 28 May 2008 to 5 May 2014). The datasets analysed during the current study are not publicly available because the patient’s informed consent only permits the data analysis and publication by the investigators.
Results
The DISCHARGE-1 cohort has been described previously.4 The present substudy included 90 (66.2%) females and 46 (33.8%) males. Median age was 56 (IQR: 47–63) years. All given data refer to the hemisphere ipsilateral to the subdural electrodes. Table 1 summarises the radiographic characteristics including haemorrhage and infarct volumes. The imageearly revealed early infarcts in 80 (58.8%) patients with a total volume of 1156.3 ml. The imagelate showed delayed infarcts in 69 (50.7%) patients with a total volume of 2599.7 ml. In addition, early and delayed infarcts are listed in Table 1 according to the five categories explained above. Because delayed cortical watershed infarcts and deep infarcts accounted for only a very small proportion of infarcts, they were not considered in further analyses. Table 1 also includes correlations of the composite delayed infarct volume in the ipsilateral ACA, MCA and PCA territories with various summary measures.
Table 1.
Number of patients/total number of patients (%) | Mean volume ± standard deviation (ml)a | Minimum–maximum in single patients (ml) | Cumulative volume over all 136 patients (ml) (% of total cumulative volume) | |
---|---|---|---|---|
bloodconvex | 118/136 (86.8%) | 2.7 ± 3.0 | 0–16.3 | 371.8 (8.9%) |
bloodinter | 131/136 (96.3%) | 3.5 ± 4.3 | 0–28.8 | 471.0 (11.3%) |
bloodSylvian | 133/136 (97.8%) | 8.1 ± 13.1 | 0–78.2 | 1099.7 (26.4%) |
bloodbasal | 132/136 (97.1%) | 4.0 ± 3.5 | 0–22.4 | 545.4 (13.1%) |
ICH | 39/136 (28.7%) | 8.1 ± 20.5 | 0–101.4 | 1103.6 (26.4%) |
IVH | 109/136 (80.1%) | 4.3 ± 10.6 | 0–70.1 | 581.3 (13.9%) |
ECIACA | 37/136 (27.2%) | 2.7 ± 11.4 | 0–105.0 | 370.5 (32.0%) |
ECIMCA | 33/136 (24.3%) | 3.5 ± 17.1 | 0–186.0 | 472.6 (40.9%) |
ECIPCA | 8/136 (5.9%) | 0.6 ± 4.3 | 0–46.7 | 87.9 (7.6%) |
ECIwatershed | 12/136 (8.8%) | 0.5 ± 3.1 | 0–34.6 | 63.1 (5.5%) |
ECIdeep | 45/136 (33.1%) | 1.2 ± 3.2 | 0–23.0 | 162.2 (14.0%) |
DCIACA | 18/136 (13.2%) | 2.9 ± 11.5 | 0–76.6 | 391.2 (15.0%) |
DCIMCA | 49/136 (36.0%) | 13.5 ± 33.9 | 0–188.0 | 1839.4 (70.8%) |
DCIPCA | 9/136 (6.6%) | 1.1 ± 6.0 | 0–50.0 | 145.3 (5.6%) |
DCIwatershed | 7/136 (5.1%) | 0.3 ± 1.8 | 0–16.2 | 43.2 (1.7%) |
DCIdeep | 30/136 (22.1%) | 1.3 ± 5.4 | 0–50.0 | 180.6 (6.9%) |
No vasospasmb | Mildc | Moderated | Severee | |
---|---|---|---|---|
DSAA1 | 38/103 | 38/103 | 16/103 | 11/103 |
DSAA2 | 47/104 | 33/104 | 18/104 | 6/104 |
DSAM1 | 54/105 | 29/105 | 17/105 | 5/105 |
DSAM2 | 47/105 | 43/105 | 12/105 | 3/105 |
DSAP1 | 70/91 | 17/91 | 3/91 | 1/91 |
DSAP2 | 77/90 | 11/90 | 2/90 | 0/90 |
Variable | Spearman coefficient | P-value | Number of patients | |
---|---|---|---|---|
Sum of DCIACA + MCA + PCA | Sum of bloodconvex + inter + Sylvian + basal | 0.21 | 0.015 | 136 |
Sum of bloodconvex + inter + Sylvian + basal + IVH | 0.17 | 0.046 | 136 | |
Average mbfvACA/MCA/PCA | 0.25 | 0.004 | 128 | |
DSAA1–P2 score | 0.26 | 0.008 | 106 | |
PTDDDdelayed | 0.55 | <0.001 | 136 | |
peakSD-delayed | 0.46 | <0.001 | 136 | |
peakisoSD-delayed | 0.47 | <0.001 | 136 | |
peakclusSD-delayed | 0.43 | <0.001 | 136 |
Statistically significant values are marked in bold.
All given data only refer to the hemisphere ipsilateral to the subdural electrodes.
Average mbfvACA/MCA/PCA = average of the peak mean blood flow velocities of anterior cerebral artery (ACA), middle cerebral artery (MCA) and posterior cerebral artery (PCA); bloodbasal = subarachnoid blood volume in the basal cisterns; bloodconvex = subarachnoid blood volume on the cerebral convexity; bloodinter = subarachnoid blood volume in the interhemispheric fissure; bloodSylvian = subarachnoid blood volume in the Sylvian fissure; DCIACA = delayed infarct volume in the territory of the ACA; DCIdeep = delayed infarct volume below the cortex including perforator infarcts, singular white matter infarcts without cortical involvement and anterior choroidal artery infarcts; DCIMCA = delayed infarct volume in the territory of the MCA; DCIPCA = delayed infarct volume in the territory of the PCA; DCIwatershed = delayed infarct volume in the territory of the cortical watershed zones; DSA = digital subtraction angiography (A1, A2, M1, M2, P1, P2 = first and second segments of ACA, MCA and PCA ipsilateral to the subdural electrodes); DSAA1–P2 score = total score achieved by the summation of values for A1, A2, M1, M2, P1 and P2 divided by the number of vessel segments assessed; ECIACA = early infarct volume in the territory of the anterior cerebral artery; ECIdeep = early infarct volume below the cortex including perforator infarcts, singular white matter infarcts without cortical involvement and anterior choroidal artery infarcts; ECIMCA = early infarct volume in the territory of the middle cerebral artery; ECIPCA = early infarct volume in the territory of the posterior cerebral artery; ECIwatershed = early infarct volume in the territory of the cortical watershed zones; ICH = intracerebral haemorrhage;
IVH = intraventricular haemorrhage; peakclusSD-delayed = peak number of clustered spreading depolarizations (SD) of a recording day during the delayed period between the early post-intervention neuroimage and the late neuroimage after completion of neuromonitoring (clustered SD = SD that occurred less than 1 h apart from the previous SD); peakisoSD-delayed = peak number of isoelectric SDs of a recording day during the delayed period (isoelectric SD = SD in electrically inactive tissue); peakSD-delayed = peak number of SDs of any type of a recording day during the delayed period; PTDDDdelayed = peak value of a recording day for the total (cumulative) SD-induced depression durations during the delayed period; sum of bloodconvex + inter + Sylvian + basal = total subarachnoid blood volume (bloodconvex + bloodinter + bloodSylvian + bloodbasal); sum of bloodconvex + inter + Sylvian + basal + IVH = bloodconvex + bloodinter + bloodSylvian + bloodbasal + IVH.
In the bottom part of the table, we added the delayed infarct volumes DCIACA + DCIMCA + DCIPCA and correlated this composite infarct volume with several summary measures, namely, the total subarachnoid blood volume (bloodconvex + bloodinter + bloodSylvian + bloodbasal) with and without IVH volume, the average of mbfvACA + mbfvMCA + and mbfvPCA, the average score based on DSAA1–P2, and the four SD variables to provide an overview. Large subarachnoid haematoma with space-occupying effect and perifocal oedema are not listed separately in this table but are included in bloodinter and bloodSylvian. In total, we encountered 22 (16.2%) such cases with large subarachnoid haematomas with a median blood volume of 29 (IQR: 16–46) ml, 19 cases in the Sylvian fissure and 3 cases in the interhemispheric fissure.
Zero values included.
Vessel narrowing <11%.
Vessel narrowing 11–33%.
Vessel narrowing 34–66%.
Vessel narrowing >66%.
Illustrative case
A 48-year-old man was admitted to the emergency room after a seizure and continued loss of consciousness. The initial CT scan demonstrated Grade 4 aSAH (modified Fisher scale) (Fig. 2A) due to rupture of a DSA-proven aneurysm at the left MCA bifurcation. On Day 1, the aneurysm was secured by surgical clip ligation and a subdural electrode strip was placed. On Day 2, MRI showed no early cerebral infarction. Due to the reduced level of consciousness, neurological assessment was limited during neurocritical care. On Day 7, an intense SD cluster suddenly began (TDDD: 324.0 min) (Fig. 3). Figure 2B gives a fluid-attenuated inversion recovery (FLAIR) image on Day 9 that revealed a new hyperintense lesion in the left temporal cortex consistent with delayed cerebral infarction in the left MCA territory. DSA on the same day showed severe angiographic vasospasm (Fig. 2C). Daily TCD examinations of the ipsilateral MCA demonstrated increased mbfvs on 2 days (>120 cm/s), but the peak mbfv of 144 cm/s on Day 8 did not reach the critical threshold of 200 cm/s.77Figure 2D visualises the spatial relation between delayed MCA infarct and location of the subdural electrodes.
Correlation analysis
Our basic hypothesis was that certain blood volumes [(i) bloodconvex; (ii) bloodinter; (iii) bloodSylvian; (iv) bloodbasal; (v) ICH and (vi) IVH] are associated with delayed infarct volumes. To this aim, we calculated Spearman correlations with delayed infarct volumes in the territories of ACA (DCIACA), MCA (DCIMCA) and PCA (DCIPCA) (Table 2). We found correlations between bloodconvex and DCIMCA (r = 0.32, P < 0.001), bloodinter and DCIACA (r = 0.19, P = 0.030), bloodSylvian and DCIMCA (r = 0.25, P = 0.003), bloodbasal and DCIMCA (r = 0.23, P = 0.008), and IVH and DCIACA (r = 0.23, P = 0.007) (Fig. 4Bi). Applying a Bonferroni correction with factor 18 (six blood volumes, three delayed infarct variables), the correlation between bloodconvex and DCIMCA remained significant. Thus, the basic hypothesis was proven for bloodconvex and DCIMCA (Fig. 4Ai).
Table 2.
Statistical analysis | Variable | Spearman coefficient | P-value | Number of patients |
---|---|---|---|---|
Association analysis with DCIACA | bloodconvex | −0.03 | 0.691 | 136 |
bloodinter | 0.19 | 0.030 | 136 | |
bloodSylvian | 0.01 | 0.899 | 136 | |
bloodbasal | 0.07 | 0.409 | 136 | |
ICH | 0.07 | 0.418 | 136 | |
IVH | 0.23 | 0.007 | 136 | |
Association analysis with DCIMCA | bloodconvex | 0.32 | <0.001 | 136 |
bloodinter | 0.09 | 0.297 | 136 | |
bloodSylvian | 0.25 | 0.003 | 136 | |
bloodbasal | 0.23 | 0.008 | 136 | |
ICH | 0.07 | 0.420 | 136 | |
IVH | 0.12 | 0.181 | 136 | |
Association analysis with DCIPCA | bloodconvex | 0.10 | 0.269 | 136 |
bloodinter | −0.05 | 0.572 | 136 | |
bloodSylvian | 0.03 | 0.704 | 136 | |
bloodbasal | 0.01 | 0.890 | 136 | |
ICH | 0.10 | 0.268 | 136 | |
IVH | 0.15 | 0.085 | 136 |
Statistically significant values are marked in bold.
All given data only refer to the hemisphere ipsilateral to the subdural electrodes. bloodbasal = subarachnoid blood volume in the basal cisterns; bloodconvex = subarachnoid blood volume on the cerebral convexity; bloodinter = subarachnoid blood volume in the interhemispheric fissure; bloodSylvian = subarachnoid blood volume in the Sylvian fissure; DCIACA = delayed infarct volume in the territory of the anterior cerebral artery; DCIMCA = delayed infarct volume in the territory of the middle cerebral artery; DCIPCA = delayed infarct volume in the territory of the posterior cerebral artery; ICH = intracerebral haemorrhage; IVH = intraventricular haemorrhage.
Then, we investigated the role of potential mediator variables (SD variables, TCD-determined peak mbfvs and DSA variables), which should be associated with blood volume variables (Table 3) and delayed infarct volume variables (Table 4). First, we investigated the correlations between blood volumes and SD variables. Because the four SD variables were highly correlated with each other, there was a clear pattern: Bloodconvex (correlations between 0.24 and 0.29) (Fig. 4Aii) and bloodSylvian (correlations between 0.21 and 0.30) were correlated with each SD variable, whereas bloodinter, bloodbasal, ICH and IVH were not. Applying a Bonferroni correction with factor 24 (six blood volumes, four SD variables), four of these eight correlations remained significant. Furthermore, SD variables were correlated with each of the delayed infarct volume variables. Correlations of SD variables were larger with DCIMCA (0.46–0.55) (Fig. 4Aiii) and smaller with DCIACA (0.18–0.23) and DCIPCA (0.19–0.26). After Bonferroni correction with factor 12 (four SD variables, three delayed infarct volume variables), each of the four correlations between SD variables and DCIMCA remained significant. Thus, using the assumption that SD variables are in the pathway between blood volume variables and delayed infarct volume variables, the role of a mediator was supported by the correlation analyses. A more precise analysis is presented in the ‘Path analysis’ section.
Table 3.
Statistical analysis | Variable | Spearman coefficient | P-value | Number of patients |
---|---|---|---|---|
Association analysis with bloodconvex | PTDDDdelayed | 0.29 | 0.001 | 136 |
peakSD-delayed | 0.25 | 0.003 | 136 | |
peakisoSD-delayed | 0.25 | 0.003 | 136 | |
peakclusSD-delayed | 0.24 | 0.005 | 136 | |
mbfvACA | 0.11 | 0.265 | 112 | |
mbfvMCA | 0.21 | 0.020 | 128 | |
mbfvPCA | 0.08 | 0.442 | 98 | |
DSAA1 | −0.01 | 0.915 | 103 | |
DSAA2 | −0.14 | 0.165 | 104 | |
DSAM1 | 0.10 | 0.302 | 105 | |
DSAM2 | 0.24 | 0.014 | 105 | |
DSAP1 | 0.05 | 0.633 | 91 | |
DSAP2 | 0.02 | 0.842 | 90 | |
Association analysis with bloodinter | PTDDDdelayed | 0.08 | 0.342 | 136 |
peakSD-delayed | 0.04 | 0.647 | 136 | |
peakisoSD-delayed | 0.05 | 0.542 | 136 | |
peakclusSD-delayed | 0.03 | 0.716 | 136 | |
mbfvACA | −0.08 | 0.420 | 112 | |
mbfvMCA | 0.00 | 0.993 | 128 | |
mbfvPCA | 0.13 | 0.215 | 98 | |
DSAA1 | 0.21 | 0.032 | 103 | |
DSAA2 | 0.31 | 0.001 | 104 | |
DSAM1 | 0.09 | 0.345 | 105 | |
DSAM2 | −0.07 | 0.454 | 105 | |
DSAP1 | −0.01 | 0.957 | 91 | |
DSAP2 | 0.05 | 0.677 | 90 | |
Association analysis with bloodSylvian | PTDDDdelayed | 0.28 | 0.001 | 136 |
peakSD-delayed | 0.25 | 0.004 | 136 | |
peakisoSD-delayed | 0.30 | <0.001 | 136 | |
peakclusSD-delayed | 0.21 | 0.016 | 136 | |
mbfvACA | −0.02 | 0.843 | 112 | |
mbfvMCA | 0.11 | 0.215 | 128 | |
mbfvPCA | 0.01 | 0.930 | 98 | |
DSAA1 | −0.06 | 0.560 | 103 | |
DSAA2 | −0.11 | 0.281 | 104 | |
DSAM1 | −0.04 | 0.654 | 105 | |
DSAM2 | 0.15 | 0.126 | 105 | |
DSAP1 | 0.05 | 0.663 | 91 | |
DSAP2 | 0.07 | 0.514 | 90 | |
Association analysis with bloodbasal | PTDDDdelayed | 0.14 | 0.100 | 136 |
peakSD-delayed | 0.09 | 0.292 | 136 | |
peakisoSD-delayed | 0.15 | 0.088 | 136 | |
peakclusSD-delayed | 0.08 | 0.331 | 136 | |
mbfvACA | −0.07 | 0.491 | 112 | |
mbfvMCA | 0.06 | 0.525 | 128 | |
mbfvPCA | 0.16 | 0.113 | 98 | |
DSAA1 | 0.16 | 0.097 | 103 | |
DSAA2 | 0.20 | 0.043 | 104 | |
DSAM1 | 0.03 | 0.761 | 105 | |
DSAM2 | −0.02 | 0.876 | 105 | |
DSAP1 | 0.08 | 0.453 | 91 | |
DSAP2 | 0.16 | 0.125 | 90 | |
Association analysis with ICH | PTDDDdelayed | 0.10 | 0.274 | 136 |
peakSD-delayed | 0.07 | 0.413 | 136 | |
peakisoSD-delayed | 0.04 | 0.622 | 136 | |
peakclusSD-delayed | 0.06 | 0.500 | 136 | |
mbfvACA | 0.08 | 0.413 | 112 | |
mbfvMCA | −0.03 | 0.703 | 128 | |
mbfvPCA | 0.03 | 0.806 | 98 | |
DSAA1 | 0.08 | 0.419 | 103 | |
DSAA2 | 0.06 | 0.548 | 104 | |
DSAM1 | 0.14 | 0.157 | 105 | |
DSAM2 | 0.04 | 0.697 | 105 | |
DSAP1 | 0.08 | 0.450 | 91 | |
DSAP2 | 0.04 | 0.691 | 90 | |
Association analysis with IVH | PTDDDdelayed | 0.05 | 0.551 | 136 |
peakSD-delayed | 0.00 | 0.977 | 136 | |
peakisoSD-delayed | −0.03 | 0.734 | 136 | |
peakclusSD-delayed | 0.03 | 0.718 | 136 | |
mbfvACA | 0.10 | 0.290 | 112 | |
mbfvMCA | 0.08 | 0.399 | 128 | |
mbfvPCA | 0.16 | 0.127 | 98 | |
DSAA1 | 0.19 | 0.058 | 103 | |
DSAA2 | 0.35 | <0.001 | 104 | |
DSAM1 | 0.17 | 0.088 | 105 | |
DSAM2 | 0.20 | 0.041 | 105 | |
DSAP1 | 0.31 | 0.003 | 91 | |
DSAP2 | 0.26 | 0.015 | 90 |
Statistically significant values are marked in bold.
All given data only refer to the hemisphere ipsilateral to the subdural electrodes. bloodbasal = subarachnoid blood volume in the basal cisterns; bloodconvex = subarachnoid blood volume on the cerebral convexity; bloodinter = subarachnoid blood volume in the interhemispheric fissure; bloodSylvian = subarachnoid blood volume in the Sylvian fissure; DSA = digital subtraction angiography [A1, A2, M1, M2, P1, P2 = first and second segments of anterior cerebral artery (ACA), middle cerebral artery (MCA) and posterior cerebral artery (PCA) ipsilateral to the subdural electrodes]; ICH = intracerebral haemorrhage; IVH = intraventricular haemorrhage; mbfvACA = transcranial Doppler-sonography (TCD)-determined peak mean blood flow velocity of ACA; mbfvMCA = TCD-determined peak mean blood flow velocity of MCA; mbfvPCA = TCD-determined peak mean blood flow velocity of PCA; peakclusSD-delayed = peak number of clustered spreading depolarizations (SD) of a recording day during the delayed period between the early post-intervention neuroimage and the late neuroimage after completion of neuromonitoring (clustered SD = SD that occurred less than 1 h apart from the previous SD); peakisoSD-delayed = peak number of isoelectric SDs of a recording day during the delayed period (isoelectric SD = SD in electrically inactive tissue); peakSD-delayed = peak number of SDs of any type of a recording day during the delayed period; PTDDDdelayed = peak value of a recording day for the total (cumulative) SD-induced depression durations during the delayed period.
Table 4.
Statistical analysis | Variable | Spearman coefficient | P-value | Number of patients |
---|---|---|---|---|
Association analysis with DCIACA | PTDDDdelayed | 0.19 | 0.024 | 136 |
peakSD-delayed | 0.18 | 0.042 | 136 | |
peakisoSD-delayed | 0.23 | 0.006 | 136 | |
peakclusSD-delayed | 0.18 | 0.033 | 136 | |
mbfvACA | 0.15 | 0.126 | 112 | |
mbfvMCA | 0.16 | 0.076 | 128 | |
mbfvPCA | 0.01 | 0.936 | 98 | |
DSAA1 | 0.23 | 0.017 | 103 | |
DSAA2 | 0.33 | 0.001 | 104 | |
DSAM1 | 0.22 | 0.025 | 105 | |
DSAM2 | 0.21 | 0.031 | 105 | |
DSAP1 | 0.33 | 0.002 | 91 | |
DSAP2 | 0.31 | 0.003 | 90 | |
Association analysis with DCIMCA | PTDDDdelayed | 0.55 | <0.001 | 136 |
peakSD-delayed | 0.47 | <0.001 | 136 | |
peakisoSD-delayed | 0.50 | <0.001 | 136 | |
peakclusSD-delayed | 0.46 | <0.001 | 136 | |
mbfvACA | 0.24 | 0.010 | 112 | |
mbfvMCA | 0.20 | 0.021 | 128 | |
mbfvPCA | 0.22 | 0.031 | 98 | |
DSAA1 | 0.21 | 0.030 | 103 | |
DSAA2 | 0.10 | 0.318 | 104 | |
DSAM1 | 0.25 | 0.012 | 105 | |
DSAM2 | 0.16 | 0.099 | 105 | |
DSAP1 | 0.08 | 0.456 | 91 | |
DSAP2 | 0.12 | 0.257 | 90 | |
Association analysis with DCIPCA | PTDDDdelayed | 0.22 | 0.012 | 136 |
peakSD-delayed | 0.26 | 0.003 | 136 | |
peakisoSD-delayed | 0.24 | 0.006 | 136 | |
peakclusSD-delayed | 0.19 | 0.031 | 136 | |
mbfvACA | 0.32 | <0.001 | 112 | |
mbfvMCA | 0.12 | 0.172 | 128 | |
mbfvPCA | 0.19 | 0.056 | 98 | |
DSAA1 | 0.11 | 0.265 | 103 | |
DSAA2 | 0.15 | 0.122 | 104 | |
DSAM1 | 0.06 | 0.563 | 105 | |
DSAM2 | −0.02 | 0.874 | 105 | |
DSAP1 | −0.02 | 0.868 | 91 | |
DSAP2 | 0.04 | 0.700 | 90 |
Statistically significant values are marked in bold.
All given data only refer to the hemisphere ipsilateral to the subdural electrodes. DCIACA = delayed infarct volume in the territory of the anterior cerebral artery; DCIMCA = delayed infarct volume in the territory of the middle cerebral artery; DCIPCA = delayed infarct volume in the territory of the posterior cerebral artery; DSA = digital subtraction angiography (A1, A2, M1, M2, P1, P2 = first and second segments of ACA, MCA and PCA ipsilateral to the subdural electrodes); ICH = intracerebral haemorrhage; IVH = intraventricular haemorrhage; mbfvACA = transcranial Doppler-sonography (TCD)-determined peak mean blood flow velocity of ACA; mbfvMCA = TCD-determined peak mean blood flow velocity of MCA; mbfvPCA = TCD-determined peak mean blood flow velocity of PCA; peakclusSD-delayed = peak number of clustered spreading depolarizations (SD) of a recording day during the delayed period between the early post-intervention neuroimage and the late neuroimage after completion of neuromonitoring (clustered SD = SD that occurred less than 1 h apart from the previous SD); peakisoSD-delayed = peak number of isoelectric SDs of a recording day during the delayed period (isoelectric SD = SD in electrically inactive tissue); peakSD-delayed = peak number of SDs of any type of a recording day during the delayed period; PTDDDdelayed = peak value of a recording day for the total (cumulative) SD-induced depression durations during the delayed period.
Applying the same procedure to peak mbfvs, we only found one correlation between bloodconvex and mbfvMCA (r = 0.21, P = 0.02), which was not significant after Bonferroni correction with factor 18 (six blood volume variables, three peak mbfvs for MCA, ACA and PCA). Of nine correlations between peak mbfvs and delayed infarct variables, four had uncorrected P-values smaller than 0.05 [mbfvMCA with DCIMCA, (r = 0.20, P = 0.02), mbfvACA with DCIMCA (r = 0.24, P = 0.01), mbfvACA with DCIPCA (r = 0.32, P < 0.001) and mbfvPCA with DCIMCA (r = 0.22, P = 0.03)]. The correlation between mbfvACA and DCIPCA remained significant after Bonferroni correction. We concluded that peak mbfvs were not a mediator variable although they were associated with delayed infarcts. Based on these results, we did not further examine this variable in the path analysis. Regarding DSA variables, we found eight correlations, one between bloodconvex and DSAM2, two between bloodinter and DSAA1 and DSAA2, none between bloodSylvian or ICH and any DSA variable, one between bloodbasal and DSAA2, and four between IVH and DSAM2, DSAA2, DSAP1 and DSAP2. Two of these correlations, bloodinter with DSAA2 (r = 0.31, P = 0.001) and IVH with DSAA2 (r = 0.35, P = 0.001) (Fig. 4Bii) remained significant after Bonferroni correction with factor 36 (six blood volumes and six DSA variables). Furthermore, we found eight correlations between DSA variables and delayed infarct volume variables. Each of the DSA variables was correlated with DCIACA, and additionally, DSAM1 and DSAA1 with DCIMCA. After Bonferroni correction with factor 18 (six DSA variables, three delayed infarct variables), the correlations of DSAA2 with DCIACA (r = 0.33, P = 0.001) (Fig. 4Biii), and of DSAP1 with DCIACA (r = 0.33, P = 0.002) remained significant. Therefore, we considered angiographic vasospasm as a potential mediator in the path analysis.
Principal component and path analysis
For each group of variables, the first principal component was used in the path analysis. We refrained from calculating a structural equation model, as single variables were far from normally distributed, although the principal components of blood volume (bloodcomponent), SD variables (SDcomponent), peak mbfvs (mbfvcomponent) and angiographic vasospasm (DSAcomponent) were close to normal distribution. In the first path model, we only included SD variables, as there were many missing values for peak mbfvs and DSA variables and our primary interest was to investigate the potential role of SDs. Standardised path coefficients (pc) were 0.22 for the path from bloodcomponent to SDcomponent (P = 0.010, z = 2.56); and 0.44 for the path from SDcomponent to the first principal component of delayed infarct volume (DCIcomponent) (P < 0.001, z = 5.54); but only 0.07 for the direct path from bloodcomponent to DCIcomponent (P = 0.36, z = 0.91) (Fig. 5A). Thus, the role of SDs as a mediator between blood volume and delayed infarct volume was confirmed.
For DSA variables, the path from DSAcomponent to DCIcomponent had a standardised pc of 0.37 (P < 0.001, z = 3.67). However, the pc was only 0.12 (P = 0.28, z = 1.08) for the path from bloodcomponent to DSAcomponent which questions the role of angiographic vasospasm as a mediator variable between blood volume and delayed infarct volume, although there was a clear association between angiographic vasospasm and delayed infarct volume. For mbfvcomponent, pc were all <0.20. Therefore, this component was not included in further analyses.
Based on these analyses, we constructed a path model with the extrinsic variables blood volume and angiographic vasospasm, one mediator variable (SD) and the outcome variable delayed infarct volume. In this model, pc did not change considerably compared to the separate analyses for SD and angiographic vasospasm: There was a path from bloodcomponent to SDcomponent (pc = 0.19, P = 0.03, z = 2.17), and from SDcomponent to DCIcomponent (pc = 0.27, P = 0.002, z = 3.06), and a direct path from DSAcomponent to DCIcomponent (pc = 0.30, P < 0.001, z = 3.65). The model showed an excellent fit (Chi-Square = 1.8, degrees of freedom = 3, P = 0.61) (Fig. 5B).
In the principal component analysis, IVH was not represented in the first component. Thus, based on the correlation analyses, we constructed a second path model with the principal component of blood volume without IVH as first and IVH as second extrinsic variable. There were two paths, one from bloodcomponent to DCIcomponent with SDcomponent as mediator variable (pc from bloodcomponent to SDcomponent = 0.23, P = 0.03, z = 2.17; pc from SDcomponent to DCIcomponent = 0.29, P = 0.002, z = 3.06), and one from IVH to DCIcomponent with DSAcomponent as mediator variable (pc from IVH to DSAcomponent = 0.24, P = 0.03, z = 2.17; pc from DSAcomponent to DCIcomponent = 0.35, P < 0.001, z = 3.65). No additional paths in this model were significant. This model also showed an excellent fit (Chi-Square = 5.3, degrees of freedom = 6, P = 0.51) (Fig. 5C).
Further associations
Supplementary Table 1 shows correlations between SD variables, DSA variables and peak mbfvs. SD and DSA variables did not correlate (Fig. 4Ci). Of 12 correlations between SD variables and peak mbfvs, 4 had uncorrected P-values smaller than 0.05. None of these remained significant after Bonferroni correction. Of 18 correlations between peak mbfvs and DSA variables, 4 had uncorrected P-values smaller than 0.05. After Bonferroni correction with factor 18 (three mbfvs, six DSA variables), the correlation between mbfvMCA with DSAM1 remained significant (Fig. 4Cii).
Discussion
It is assumed that the amount of subarachnoid blood on the initial CT scan predicts DCI.1Supplementary Table 2 lists the studies we found in which blood was quantified and all studies supported this.79-84 Our study basically reaches the same conclusion. However, we also quantified blood in the sulci of the cerebral convexity, and this component had the strongest statistical association with delayed infarcts in the MCA territory, which in turn accounted for 70.8% of the total cumulative infarct volume in the 136 patients. In fact, only the correlation between bloodconvex and DCIMCA remained significant with strict Bonferroni correction. However, with 18 tests, only 1 uncorrected significant result is expected by chance, and we observed such significances in 5 tests (Table 2). Four of these were related to the same fundamental hypothesis—local blood deposition on the cortex contributes to delayed infarct pathogenesis. Therefore, we estimate Bonferroni correction to be very conservative here and believe that the fundamental hypothesis above is also supported by the additional tests, which were significant without Bonferroni correction. For example, bloodinter without Bonferroni correction correlated significantly with delayed infarcts in the ACA territory adjacent to the interhemispheric fissure, and bloodSylvian showed the second strongest correlation with delayed infarcts in the MCA territory surrounding the Sylvian fissure.
Human autopsy studies shaped the hypothesis that local blood deposition on the cortex is largely responsible for infarcts after aSAH,55 which is further supported by radiological findings61,85-87 and a primate study.63 This hypothesis implies that direct exposure to factors released from the clot is critically involved in cortical infarct development below the clot. Experimentally, an important effect of such factors is to induce SDs, which in turn initiate and maintain neuronal cytotoxic oedema associated with the risk of developing into infarction. Consistently, focal accumulation of subarachnoid blood was a sufficient insult to trigger SDs and early infarcts in a swine model.47 SD induction was also previously demonstrated in a rat model mimicking post-aSAH conditions.21 In this model, artificial cerebrospinal fluid (aCSF), with an increased K+ concentration ([K+]aCSF) and either a nitric oxide synthase (NOS) inhibitor or the nitric oxide (NO) scavenger haemoglobin, was applied topically on the brain.21 The same protocol also induced SDs in brain slices devoid of intact blood circulation.39 For the complex role of K+, the reader is referred to previous work.5,88 The prominent role of decreased NO availability agrees well with the increasingly recognised hypothesis, originally from Furchgott et al., that clot-derived factors cause NO deficiency after aSAH.57,58,89,90 NO deficiency leads directly to vasoconstriction and, by absence of its permissive effect for other vasodilators, indirectly as well.5,58 NO deficiency also lowers the SD threshold. This was found not only in vivo24 but also in brain slices39 devoid of intact blood circulation. Previous work suggested that loss of cyclic guanosine monophosphate (cGMP)-independent modulatory effects of NO on neuronal P/Q-type voltage-gated Ca2+ channels and N-methyl-D-aspartate receptor-controlled channels are responsible for this.91 However, even in absence of NO-lowering agents, increased microvascular tone can cause SDs due to an imbalance between energy supply and demand of neurons. This was demonstrated in an in vivo model with ascending epipially applied concentrations of the vasoconstrictor polypeptide endothelin-1, which failed in brain slices.92 There are both arguments in favour of and against vasoconstriction triggering SDs after aSAH.93 For example, this hypothesis is supported by the fact that SD-induced spreading ischaemia leading to cerebral infarction started at a median ptiO2 of 12.5 (IQR: 9.2, 15.2) mmHg,16 which is already below the normal range.94 During spreading ischaemia, ptiO2 then fell further to 3.3 (2.4, 7.4) mmHg.16 Similarly, rCBF showed a downward trend even before the onset of SD-induced spreading ischaemia. Immediately before the onset of the spreading ischaemia leading to infarction, rCBF was 57 (53, 65) % compared to baseline and then dropped to 26 (16, 42) % during the spreading ischaemia.16 On the other hand, it argues against the hypothesis of vasoconstriction being responsible for SDs after aSAH that DSA-derived peripheral cerebral circulation time as a measure of microcirculatory resistance did not correlate with SD variables or DCI in patients.95 In addition, SD clusters after aSAH correlate strongly with clinical neurologic deficits, but there are cases of aSAH patients in whom SD clusters were not followed by delayed infarcts but only by reversible delayed vasogenic cortex oedema, reminiscent of MRI findings in familial hemiplegic migraine.4 In the present study, we cannot clarify the exact pathomechanisms by which SDs arise, but we found evidence that subarachnoid clots overlying the cortex are associated with SD variables, that SD variables are significantly associated with delayed infarcts, and that the SD component is a statistical mediator between subarachnoid blood and delayed infarcts. The fact that extravascular blood products and especially haemoglobin have complex degradation pathways96 that may vary from patient to patient and could have an important influence on the development of DCI and even beyond on patient outcome could not be considered in the present study for methodological reasons. Iron deposits, which are likely toxic and an end product of these degradation pathways, can still be detected in the cortex months after the initial haemorrhage, which may further worsen long-term patient outcomes.61,97
Analysis of angiographic vasospasm revealed that both the correlation of bloodinter and IVH with DSAA2 remained significant with strict Bonferroni correction. Furthermore, only two uncorrected significant results are expected by chance in 36 tests, but we observed such significances in a total of 8 correlations between blood and DSA variables (Table 3). In the correlation analyses between DSA variables and delayed infarcts, two correlations remained significant with Bonferroni correction. Without Bonferroni correction, we observed significances in eight correlations, while only one uncorrected significant result would be expected by chance. Overall, this supports an association between blood volume and DSA variables and another association between DSA variables and delayed infarcts. In the path analyses, the DSA component was a statistical mediator in a path from IVH to delayed infarcts. Possibly, blood products from the ventricles slowly move to the venous system via the glymphatic system, i.e. via para-arterial spaces. In this way, they could reach the arterial tunica media and induce a local and, via conduction mechanisms between myocytes, also more widespread vasospasm. A prominent role of IVH for angiographic vasospasm has been discussed previously, for example, in the context of angiographic vasospasm after rupture of arteriovenous malformations.98,99
SD and DSA variables did not correlate. Of 12 correlations between SD variables and peak mbfvs, 4 had uncorrected P-values <0.05, while <1 would have been expected by chance. However, none of these correlations remained significant after Bonferroni correction. Reduced perfusion from proximal vasospasm should favour SDs according to animal studies,5,92 but in agreement with previous clinical observations, we found no statistically significant evidence for this.4,95
Cerebral infarction is tissue death (necrosis) in which, in addition to SD/neuronal cytotoxic oedema, a lack of rCBF to the tissue, commonly referred to as ischaemia, occurred before the development of necrosis. As explained in the ‘Introduction’ section, cerebral ischaemia may occur primarily and trigger secondary SD/neuronal cytotoxic oedema with a delay of 1–5 min, such as after MCA occlusion,16 or SD/neuronal cytotoxic oedema may occur primarily, e.g. as a result of primary neuronal or astrocytic disruption or local inflammation, and trigger spreading ischaemia within seconds via the mechanism of the inverse haemodynamic response.5,21 The standard experimental protocol for causing spreading ischaemia is brain topical application of aCSF containing elevated [K+]aCSF combined with either an NOS inhibitor or the NO scavenger haemoglobin.21 The original hypothesis in 1998 that spreading ischaemia might be a pathophysiological correlate of delayed infarcts after aSAH was based on the consideration that the release of blood products from the clot creates a microenvironment similar to that which experimentally leads to spreading ischaemia.21 Indeed, the phenomenology of spreading ischaemia later recorded in aSAH patients using subdural optoelectrode strips and oxygen sensors is not different from experimentally recorded spreading ischaemia in the animal model.4,16,22 In 2018, using neuromonitoring in combination with longitudinal neuroimaging, the entire sequence of infarct development after aSAH with SD-induced persistent activity depression, SD-induced spreading ischaemia and transition from clustered SDs to NUP was demonstrated in a small patient population where the recording devices were located directly in the area of newly developing infarcts.16 The concept that local factors at the cortex surface suffice to initiate the mechanism of spreading ischaemia21 is also consistent with observations in DISCHARGE-1 that 14.5% of patients with delayed infarcts had no angiographic vasospasm and 50% had only relatively mild angiographic vasospasm.4 The often extreme hyperaemia typically observed in aSAH patients immediately following severe spreading ischaemia also argues against sustained upstream restriction of rCBF as the principal cause of spreading ischaemia, as sustained upstream restriction of rCBF would not allow hyperaemia of such high amplitude to occur (compare figure 7 in Dreier et al.22 and figure 6A in Luckl et al.16). Nevertheless, experimentally, upstream reduction in rCBF further shifts the normal haemodynamic response to SD towards the inverse haemodynamic response.70,100 That is, proximal vasospasm should exacerbate spreading ischaemia, although this may not necessarily translate into a statistically significant change in SD count or depression periods, which, after all, are measured in 71% of patients with electrodes outside the ischaemic zone proper, i.e. outside the zone where spreading ischaemia occurs.4
Conclusion
We found that SDs are a statistical mediator between subarachnoid blood and delayed infarcts. Our results suggest that especially the blood in sulci and fissures, which was usually not considered in previous analyses, plays a major role in the pathogenesis of delayed infarcts. Thus, delayed infarcts may depend on downstream rather than upstream mechanisms and on not only vascular but also important parenchymal factors. This may explain why robust antagonization of proximal vasospasm alone did not suffice to effectively prevent delayed infarcts.101-103 However, our results also support that angiographic vasospasm, SD and spreading ischaemia are not mutually exclusive pathomechanisms but complement each other, and we would therefore advocate that therapeutic combination approaches also be pursued further. A limitation of our study is the restricted spatial sampling with only six subdural electrodes. The majority of the electrodes were typically located over MCA territory. Accordingly, the correlation between SD variables and DCIMCA was higher than the correlations between SD variables and DCIACA or DCIPCA. On the other hand, the fact that correlations between SD variables and DCIACA or DCIPCA were also statistically significant illustrates once again that subdural neuromonitoring affords even remote detection of injury because SDs propagate widely from metabolically stressed zones.72 This is a particular advantage of ECoG over other neuromonitoring modalities, such as microdialysis and partial pressure of oxygen measurements, that measure only local conditions and may not detect clinically important changes developing elsewhere in the hemisphere. Remote diagnosis of new ischaemic zones is of particular relevance to patients with aSAH because the exact location of future developing pathology is usually unknown when the neurosurgeon implants neuromonitoring devices.
Supplementary Material
Acknowledgements
We thank all the trial participants for their participation in the study and commitment to advancing knowledge regarding aSAH and focal brain damage. We would like to thank the study nurses and the nursing staff of the participating intensive care units, without whose help this study would not have been possible. We appreciate the data and safety monitoring board.
Abbreviations
- ACA =
anterior cerebral artery
- aCSF =
artificial cerebrospinal fluid
- aSAH =
aneurysmal subarachnoid haemorrhage
- bloodbasal =
subarachnoid blood volume in the basal cisterns
- bloodcomponent =
first principal component of the blood volume variables
- bloodconvex =
subarachnoid blood volume on the cerebral convexity
- bloodinter =
subarachnoid blood volume in the interhemispheric fissure
- bloodSylvian =
subarachnoid blood volume in the Sylvian fissure
- CBF =
cerebral blood flow
- COSBID =
Co-Operative Studies on Brain Injury Depolarisations
- CTA =
computed tomography angiography
- DC potential =
direct current (steady) potential
- DCI =
delayed cerebral ischaemia
- DCIACA =
delayed infarct volume in the territory of the anterior cerebral artery
- DCIdeep =
delayed infarct volume below the cortex, including perforator infarcts, singular white matter infarcts without cortical involvement and anterior choroidal artery infarcts
- DCIMCA =
delayed infarct volume in the territory of the middle cerebral artery
- DCIPCA =
delayed infarct volume in the territory of the posterior cerebral artery
- DCIwatershed =
delayed infarct volume in the territory of the cortical watershed zones
- DISCHARGE-1 =
Depolarisations in ISCHaemia after subARachnoid haemorrhaGE-1
- DSA =
digital subtraction angiography [A1, A2, M1, M2, P1, P2 = first and second segments of anterior cerebral artery (ACA), middle cerebral artery (MCA) and posterior cerebral artery (PCA) ipsilateral to the subdural electrodes]
- DSAcomponent =
first principal component of the digital subtraction angiography variables to quantify the degree of vasospasm
- ECI =
early cerebral ischaemia
- ECIACA =
early infarct volume in the territory of the anterior cerebral artery
- ECIdeep =
early infarct volume below the cortex including perforator infarcts, singular white matter infarcts without cortical involvement and anterior choroidal artery infarcts
- ECIMCA =
early infarct volume in the territory of the middle cerebral artery
- ECIPCA =
early infarct volume in the territory of the posterior cerebral artery
- ECIwatershed =
early infarct volume in the territory of the cortical watershed zones
- ECoG =
electrocorticography
- eGOS =
extended Glasgow Outcome Scale
- FLAIR =
fluid-attenuated inversion recovery
- ICH =
intracerebral haemorrhage
- Imageearly =
post-interventional MRI or CT performed no later than Day 5
- Imagelate =
follow-up MRI or CT performed after the end of neuromonitoring around Day 14
- IQR =
interquartile range
- IVH =
intraventricular haemorrhage
- [K+]aCSF =
potassium concentration in the artificial cerebrospinal fluid
- mbfv =
transcranial Doppler-sonography (TCD)-determined mean blood flow velocity
- mbfvACA =
TCD-determined peak mean blood flow velocity of the anterior cerebral artery
- mbfvcomponent =
first principal component of the TCD-determined peak mean blood flow velocity variables
- mbfvMCA =
TCD-determined peak mean blood flow velocity of the middle cerebral artery
- mbfvPCA =
TCD-determined peak mean blood flow velocity of the posterior cerebral artery
- MCA =
middle cerebral artery
- NO =
nitric oxide
- NOS =
nitric oxide synthase
- NUP =
negative ultraslow potential
- pc =
path coefficients
- PCA =
posterior cerebral artery
- peakclusSD-delayed =
peak number of clustered spreading depolarizations (SD) of a recording day during the delayed period between the early post-intervention neuroimage and the late neuroimage after completion of neuromonitoring (clustered SD = SD that occurred less than 1 h apart from the previous SD)
- peakisoSD-delayed =
peak number of isoelectric SDs of a recording day during the delayed period (isoelectric SD = SD in electrically inactive tissue)
- peakSD-delayed =
peak number of SDs of any type of a recording day during the delayed period
- PTDDDdelayed =
peak value of a recording day for the total (cumulative) SD-induced depression durations during the delayed period
- rCBF =
regional cerebral blood flow
- SD =
spreading depolarization
- TCD =
transcranial Doppler-sonography
- TDDD =
total (cumulative) spreading depolarization-induced depression duration of a recording day
Contributor Information
Viktor Horst, Centre for Stroke Research Berlin, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Vasilis Kola, Centre for Stroke Research Berlin, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Coline L Lemale, Centre for Stroke Research Berlin, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Department of Experimental Neurology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Sebastian Major, Centre for Stroke Research Berlin, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Department of Experimental Neurology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Department of Neurology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Maren K L Winkler, Centre for Stroke Research Berlin, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Robert Koch Institute, Berlin, Germany.
Nils Hecht, Centre for Stroke Research Berlin, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Department of Neurosurgery, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Edgar Santos, Department of Neurosurgery, Heidelberg University Hospital, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.
Johannes Platz, Department of Neurosurgery, Herz-Neuro-Zentrum Bodensee, Kreuzlingen, Switzerland.
Oliver W Sakowitz, Department of Neurosurgery, Heidelberg University Hospital, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.
Hartmut Vatter, Department of Neurosurgery, University Hospital and Friedrich-Wilhelms-University Bonn, Bonn, Germany.
Christian Dohmen, Department for Neurology and Neurological Intensive Care Medicine, LVR-Klinik Bonn, Bonn, Germany.
Michael Scheel, Department of Neuroradiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Peter Vajkoczy, Centre for Stroke Research Berlin, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Department of Neurosurgery, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Jed A Hartings, Department of Neurosurgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Johannes Woitzik, Centre for Stroke Research Berlin, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Department of Neurosurgery, Evangelisches Krankenhaus Oldenburg, University of Oldenburg, Oldenburg, Germany.
Peter Martus, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany.
Jens P Dreier, Centre for Stroke Research Berlin, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Department of Experimental Neurology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Department of Neurology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Bernstein Centre for Computational Neuroscience Berlin, Berlin, Germany; Einstein Centre for Neurosciences Berlin, Berlin, Germany.
Supplementary material
Supplementary material is available at Brain Communications online.
Funding
This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (German Research Council) (DFG DR 323/5-1 to O.W.S., H.V., P.V., J.W., P.M. and J.P.D.; DFG DR 323/10-1 to J.P.D.) and BMBF Bundesministerium fuer Bildung und Forschung (Era-Net Neuron EBio2, with funds from BMBF 01EW2004) to J.P.D. N.H. is Berlin Institute of Health Clinical Fellow, funded by Stiftung Charité.
Competing interests
The authors report no competing interests.
References
- 1. Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389(10069):655–666. [DOI] [PubMed] [Google Scholar]
- 2. Lawton MT, Vates GE. Subarachnoid hemorrhage. N Engl J Med. 2017;377(3):257–266. [DOI] [PubMed] [Google Scholar]
- 3. Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology. 1998;50(5):1413–1418. [DOI] [PubMed] [Google Scholar]
- 4. Dreier JP, Winkler MKL, Major S, et al. Spreading depolarizations in ischaemia after subarachnoid haemorrhage, a diagnostic phase III study. Brain. 2022;145(4):1264–1284. [DOI] [PubMed] [Google Scholar]
- 5. Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 2011;17(4):439–447. [DOI] [PubMed] [Google Scholar]
- 6. Westermaier T, Pham M, Stetter C, et al. Value of transcranial Doppler, perfusion-CT and neurological evaluation to forecast secondary ischemia after aneurysmal SAH. Neurocrit Care. 2014;20(3):406–412. [DOI] [PubMed] [Google Scholar]
- 7. Dreier JP, Isele T, Reiffurth C, et al. Is spreading depolarization characterized by an abrupt, massive release of Gibbs free energy from the human brain cortex? Neuroscientist. 2013;19(1):25–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Dreier JP, Reiffurth C. The stroke-migraine depolarization continuum. Review. Neuron. 2015;86(4):902–922. [DOI] [PubMed] [Google Scholar]
- 9. Kirov SA, Fomitcheva IV, Sword J. Rapid neuronal ultrastructure disruption and recovery during spreading depolarization-induced cytotoxic edema. Cereb Cortex. 2020;30(10):5517–5531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Dreier JP, Lemale CL, Kola V, Friedman A, Schoknecht K. Spreading depolarization is not an epiphenomenon but the principal mechanism of the cytotoxic edema in various gray matter structures of the brain during stroke. Neuropharmacology. 2018;134(Pt B):189–207. [DOI] [PubMed] [Google Scholar]
- 11. Lemale CL, Luckl J, Horst V, et al. Migraine aura, transient ischemic attacks, stroke, and dying of the brain share the same key pathophysiological process in neurons driven by Gibbs-Donnan forces, namely spreading depolarization. Front Cell Neurosci. 2022;16:837650. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Gerkau NJ, Rakers C, Petzold GC, Rose CR. Differential effects of energy deprivation on intracellular sodium homeostasis in neurons and astrocytes. J Neurosci Res. 2017;95(11):2275–2285. [DOI] [PubMed] [Google Scholar]
- 13. Windmuller O, Lindauer U, Foddis M, et al. Ion changes in spreading ischaemia induce rat middle cerebral artery constriction in the absence of NO. Brain. 2005;128(Pt 9):2042–2051. [DOI] [PubMed] [Google Scholar]
- 14. Hansen AJ, Zeuthen T. Extracellular ion concentrations during spreading depression and ischemia in the rat brain cortex. Acta Physiol Scand. 1981;113(4):437–445. [DOI] [PubMed] [Google Scholar]
- 15. Kraig RP, Nicholson C. Extracellular ionic variations during spreading depression. Neuroscience. 1978;3(11):1045–1059. [DOI] [PubMed] [Google Scholar]
- 16. Luckl J, Lemale CL, Kola V, et al. The negative ultraslow potential, electrophysiological correlate of infarction in the human cortex. Brain. 2018;141(6):1734–1752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Vinokurova D, Zakharov A, Chernova K, et al. Depth-profile of impairments in endothelin-1-induced focal cortical ischemia. J Cereb Blood Flow Metab. 2022;42(10):1944-1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Jarvis CR, Anderson TR, Andrew RD. Anoxic depolarization mediates acute damage independent of glutamate in neocortical brain slices. Cereb Cortex. 2001;11(3):249–259. [DOI] [PubMed] [Google Scholar]
- 19. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994;117(Pt 1):199–210. [DOI] [PubMed] [Google Scholar]
- 20. Van Harreveld A, Ochs S. Electrical and vascular concomitants of spreading depression. Am J Physiol. 1957;189(1):159–166. [DOI] [PubMed] [Google Scholar]
- 21. Dreier JP, Korner K, Ebert N, et al. Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab. 1998;18(9):978–990. [DOI] [PubMed] [Google Scholar]
- 22. Dreier JP, Major S, Manning A, et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain. 2009;132(Pt 7):1866–1881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Nedergaard M, Hansen AJ. Spreading depression is not associated with neuronal injury in the normal brain. Brain Res. 1988;449(1–2):395–398. [DOI] [PubMed] [Google Scholar]
- 24. Dreier JP, Ebert N, Priller J, et al. Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: A model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg. 2000;93(4):658–666. [DOI] [PubMed] [Google Scholar]
- 25. Shin HK, Dunn AK, Jones PB, Boas DA, Moskowitz MA, Ayata C. Vasoconstrictive neurovascular coupling during focal ischemic depolarizations. J Cereb Blood Flow Metab. 2006;26(8):1018–1030. [DOI] [PubMed] [Google Scholar]
- 26. Strong AJ, Anderson PJ, Watts HR, et al. Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex. Brain. 2007;130(Pt 4):995–1008. [DOI] [PubMed] [Google Scholar]
- 27. Bere Z, Obrenovitch TP, Kozak G, Bari F, Farkas E. Imaging reveals the focal area of spreading depolarizations and a variety of hemodynamic responses in a rat microembolic stroke model. Research Support, Non-U.S. Gov't. J Cereb Blood Flow Metab. 2014;34(10):1695–1705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Zhao HT, Tuohy MC, Chow D, et al. Neurovascular dynamics of repeated cortical spreading depolarizations after acute brain injury. Cell Rep. 2021;37(1):109794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Takeda Y, Zhao L, Jacewicz M, Pulsinelli WA, Nowak TS Jr. Metabolic and perfusion responses to recurrent peri-infarct depolarization during focal ischemia in the spontaneously hypertensive rat: Dominant contribution of sporadic CBF decrements to infarct expansion. J Cereb Blood Flow Metab. 2011;31(9):1863–1873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Dreier JP, Kleeberg J, Alam M, et al. Endothelin-1-induced spreading depression in rats is associated with a microarea of selective neuronal necrosis. Exp Biol Med (Maywood). 2007;232(2):204–213. [PubMed] [Google Scholar]
- 31. Unekawa M, Tomita Y, Masamoto K, Kanno I, Nakahara J, Izawa Y. Close association between spreading depolarization and development of infarction under experimental ischemia in anesthetized male mice. Brain Res. 2022;1792:148023. [DOI] [PubMed] [Google Scholar]
- 32. Higuchi T, Takeda Y, Hashimoto M, Nagano O, Hirakawa M. Dynamic changes in cortical NADH fluorescence and direct current potential in rat focal ischemia: Relationship between propagation of recurrent depolarization and growth of the ischemic core. J Cereb Blood Flow Metab. 2002;22(1):71–79. [DOI] [PubMed] [Google Scholar]
- 33. Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol. 2010;67(2):221–229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Maslarova A, Alam M, Reiffurth C, Lapilover E, Gorji A, Dreier JP. Chronically epileptic human and rat neocortex display a similar resistance against spreading depolarization in vitro. Stroke. 2011;42(10):2917–2922. [DOI] [PubMed] [Google Scholar]
- 35. Gorji A, Scheller D, Straub H, et al. Spreading depression in human neocortical slices. Brain Res. 2001;906(1–2):74–83. [DOI] [PubMed] [Google Scholar]
- 36. Dreier JP, Major S, Pannek HW, et al. Spreading convulsions, spreading depolarization and epileptogenesis in human cerebral cortex. Brain. 2012;135(Pt 1):259–275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Avoli M, Drapeau C, Louvel J, Pumain R, Olivier A, Villemure JG. Epileptiform activity induced by low extracellular magnesium in the human cortex maintained in vitro. Ann Neurol. 1991;30(4):589–596. [DOI] [PubMed] [Google Scholar]
- 38. Petzold GC, Windmuller O, Haack S, et al. Increased extracellular K+ concentration reduces the efficacy of N-methyl-D-aspartate receptor antagonists to block spreading depression-like depolarizations and spreading ischemia. Stroke. 2005;36(6):1270–1277. [DOI] [PubMed] [Google Scholar]
- 39. Petzold GC, Haack S, von Bohlen Und Halbach O, et al. Nitric oxide modulates spreading depolarization threshold in the human and rodent cortex. Stroke. 2008;39(4):1292–1299. [DOI] [PubMed] [Google Scholar]
- 40. Köhling R, Koch UR, Hagemann G, Redecker C, Straub H, Speckmann EJ. Differential sensitivity to induction of spreading depression by partial disinhibition in chronically epileptic human and rat as compared to native rat neocortical tissue. Brain Res. 2003;975(1–2):129–134. [DOI] [PubMed] [Google Scholar]
- 41. Dreier JP, Woitzik J, Fabricius M, et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain. 2006;129(Pt 12):3224–3237. [DOI] [PubMed] [Google Scholar]
- 42. Sugimoto K, Nomura S, Shirao S, et al. Cilostazol decreases duration of spreading depolarization and spreading ischemia after aneurysmal subarachnoid hemorrhage. Ann Neurol. 2018;84(6):873–885. [DOI] [PubMed] [Google Scholar]
- 43. Major S, Huo S, Lemale CL, et al. Direct electrophysiological evidence that spreading depolarization-induced spreading depression is the pathophysiological correlate of the migraine aura and a review of the spreading depolarization continuum of acute neuronal mass injury. Geroscience. 2020;42(1):57–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Fabricius M, Fuhr S, Willumsen L, et al. Association of seizures with cortical spreading depression and peri-infarct depolarisations in the acutely injured human brain. Clin Neurophysiol. 2008;119(9):1973–1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Revankar GS, Winkler MKL, Major S, et al. Spreading depolarizations and seizures in clinical subdural electrocorticographic recordings. In: Varelas PN, Claassen J, eds. Seizures in critical care A guide to diagnosis and therapeutics. Springer; 2017:77–90. [Google Scholar]
- 46. Oliveira-Ferreira AI, Milakara D, Alam M, et al. Experimental and preliminary clinical evidence of an ischemic zone with prolonged negative DC shifts surrounded by a normally perfused tissue belt with persistent electrocorticographic depression. J Cereb Blood Flow Metab. 2010;30(8):1504–1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Hartings JA, York J, Carroll CP, et al. Subarachnoid blood acutely induces spreading depolarizations and early cortical infarction. Brain. 2017;140(10):2673–2690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Eriksen N, Rostrup E, Fabricius M, et al. Early focal brain injury after subarachnoid hemorrhage correlates with spreading depolarizations. Neurology. 2019;92(4):e326–e341. [DOI] [PubMed] [Google Scholar]
- 49. Drenckhahn C, Winkler MK, Major S, et al. Correlates of spreading depolarization in human scalp electroencephalography. Brain. 2012;135(Pt 3):853–868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Carlson AP, Shuttleworth CW, Major S, Lemale CL, Dreier JP, Hartings JA. Terminal spreading depolarizations causing electrocortical silencing prior to clinical brain death: Case report. J Neurosurg. 2019;131(6):1773–1779. [DOI] [PubMed] [Google Scholar]
- 51. Dreier JP, Major S, Lemale CL, et al. Correlates of spreading depolarization, spreading depression, and negative ultraslow potential in epidural versus subdural electrocorticography. Front Neurosci. 2019;13:373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Dreier JP, Major S, Foreman B, et al. Terminal spreading depolarization and electrical silence in death of human cerebral cortex. Ann Neurol. 2018;83(2):295–310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Fiehler J, Knudsen K, Kucinski T, et al. Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke. 2004;35(2):514–519. [DOI] [PubMed] [Google Scholar]
- 54. Cain SM, Bohnet B, LeDue J, et al. In vivo imaging reveals that pregabalin inhibits cortical spreading depression and propagation to subcortical brain structures. Proc Natl Acad Sci U S A. 2017;114(9):2401–2406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Stoltenburg-Didinger G, Schwarz K. Brain lesions secondary to subarachnoid hemorrhage due to ruptured aneurysms. In: Cervós-Navarro J, Ferszt R, eds. Stroke and microcirculation. Raven Press; 1987:471–480. [Google Scholar]
- 56. Ohkuma H, Manabe H, Tanaka M, Suzuki S. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2000;31(7):1621–1627. [DOI] [PubMed] [Google Scholar]
- 57. Furchgott RF, Martin W, Cherry PD. Blockade of endothelium-dependent vasodilation by hemoglobin: A possible factor in vasospasm associated with hemorrhage. Adv Prostaglandin Thromboxane Leukot Res. 1985;15:499–502. [PubMed] [Google Scholar]
- 58. Pluta RM, Hansen-Schwartz J, Dreier J, et al. Cerebral vasospasm following subarachnoid hemorrhage: Time for a new world of thought. Neurol Res. 2009;31(2):151–158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Neil-Dwyer G, Lang DA, Doshi B, Gerber CJ, Smith PW. Delayed cerebral ischaemia: The pathological substrate. Acta Neurochir (Wien). 1994;131(1–2):137–145. [DOI] [PubMed] [Google Scholar]
- 60. Robertson EG. Cerebral lesions due to intracranial aneurysms. Brain. 1949;72(Pt 2):150–185. [DOI] [PubMed] [Google Scholar]
- 61. Dreier JP, Sakowitz OW, Harder A, et al. Focal laminar cortical MR signal abnormalities after subarachnoid hemorrhage. Ann Neurol. 2002;52(6):825–829. [DOI] [PubMed] [Google Scholar]
- 62. Birse SH, Tom MI. Incidence of cerebral infarction associated with ruptured intracranial aneurysms. A study of 8 unoperated cases of anterior cerebral aneurysm. Neurology. 1960;10:101–106. [DOI] [PubMed] [Google Scholar]
- 63. Schatlo B, Dreier JP, Glasker S, et al. Report of selective cortical infarcts in the primate clot model of vasospasm after subarachnoid hemorrhage. Neurosurgery. 2010;67(3):721–8; discussion 728–9. [DOI] [PubMed] [Google Scholar]
- 64. Dreier JP, Petzold G, Tille K, et al. Ischaemia triggered by spreading neuronal activation is inhibited by vasodilators in rats. J Physiol. 2001;531(Pt 2):515–526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Dreier JP, Windmuller O, Petzold G, Lindauer U, Einhaupl KM, Dirnagl U. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats. Neurosurgery. 2002;51(6):1457-1465; discussion 1465-1467. [PubMed] [Google Scholar]
- 66. Dijkhuizen RM, Beekwilder JP, van der Worp HB, Berkelbach van der Sprenkel JW, Tulleken KA, Nicolay K. Correlation between tissue depolarizations and damage in focal ischemic rat brain. Brain Res. 1999;840(1–2):194–205. [DOI] [PubMed] [Google Scholar]
- 67. Koroleva VI, Bures J. The use of spreading depression waves for acute and long-term monitoring of the penumbra zone of focal ischemic damage in rats. Proc Natl Acad Sci U S A. 1996;93(8):3710–3714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Nedergaard M, Hansen AJ. Characterization of cortical depolarizations evoked in focal cerebral ischemia. J Cereb Blood Flow Metab. 1993;13(4):568–574. [DOI] [PubMed] [Google Scholar]
- 69. Strong AJ, Smith SE, Whittington DJ, et al. Factors influencing the frequency of fluorescence transients as markers of peri-infarct depolarizations in focal cerebral ischemia. Stroke. 2000;31(1):214–222. [DOI] [PubMed] [Google Scholar]
- 70. Feuerstein D, Takagaki M, Gramer M, et al. Detecting tissue deterioration after brain injury: Regional blood flow level versus capacity to raise blood flow. Research Support, Non-U.S. Gov't. J Cereb Blood Flow Metab. 2014;34(7):1117–1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Woitzik J, Hecht N, Pinczolits A, et al. Propagation of cortical spreading depolarization in the human cortex after malignant stroke. Research Support, Non-U.S. Gov't. Neurology. 2013;80(12):1095–1102. [DOI] [PubMed] [Google Scholar]
- 72. Dreier JP, Fabricius M, Ayata C, et al. Recording, analysis, and interpretation of spreading depolarizations in neurointensive care: Review and recommendations of the COSBID research group. J Cereb Blood Flow Metab. 2017;37(5):1595–1625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Hartings JA, Andaluz N, Bullock MR, et al. Prognostic value of spreading depolarizations in patients with severe traumatic brain injury. JAMA Neurol. 2020;77(4):489–499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Weidauer S, Lanfermann H, Raabe A, Zanella F, Seifert V, Beck J. Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: A prospective MRI and DSA study. Stroke. 2007;38(6):1831–1836. [DOI] [PubMed] [Google Scholar]
- 75. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: Cerebral hemispheres. Neurology. 1998;50(6):1699–1708. [DOI] [PubMed] [Google Scholar]
- 76. van der Zande JJ, Hendrikse J, Rinkel GJ. CT Angiography for differentiation between intracerebral and intra-sylvian hematoma in patients with ruptured middle cerebral artery aneurysms. Am J Neuroradiol. 2011;32(2):271–275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Vora YY, Suarez-Almazor M, Steinke DE, Martin ML, Findlay JM. Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery. 1999;44(6):1237-1247; discussion 1247-1248. [PubMed] [Google Scholar]
- 78. Bollen KA. Structural equations with latent variables. John Wiley and Sons, Inc.; 1989. [Google Scholar]
- 79. Ko SB, Choi HA, Carpenter AM, et al. Quantitative analysis of hemorrhage volume for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Stroke. 2011;42(3):669–674. [DOI] [PubMed] [Google Scholar]
- 80. Reilly C, Amidei C, Tolentino J, Jahromi BS, Macdonald RL. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004;101(2):255–261. [DOI] [PubMed] [Google Scholar]
- 81. van der Steen WE, Zijlstra IA, Verbaan D, et al. Association of quantified location-specific blood volumes with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Am J Neuroradiol. 2018;39(6):1059–1064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. van der Steen WE, Leemans EL, van den Berg R, et al. Radiological scales predicting delayed cerebral ischemia in subarachnoid hemorrhage: Systematic review and meta-analysis. Neuroradiology. 2019;61(3):247–256. [DOI] [PubMed] [Google Scholar]
- 83. Friedman JA, Goerss SJ, Meyer FB, et al. Volumetric quantification of Fisher grade 3 aneurysmal subarachnoid hemorrhage: A novel method to predict symptomatic vasospasm on admission computerized tomography scans. J Neurosurg. 2002;97(2):401–407. [DOI] [PubMed] [Google Scholar]
- 84. Zijlstra IA, Gathier CS, Boers AM, et al. Association of automatically quantified total blood volume after aneurysmal subarachnoid hemorrhage with delayed cerebral ischemia. Am J Neuroradiol. 2016;37(9):1588–1593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Weidauer S, Vatter H, Beck J, et al. Focal laminar cortical infarcts following aneurysmal subarachnoid haemorrhage. Neuroradiology. 2008;50(1):1–8. [DOI] [PubMed] [Google Scholar]
- 86. Schinke C, Horst V, Schlemm L, et al. A case report of delayed cortical infarction adjacent to sulcal clots after traumatic subarachnoid hemorrhage in the absence of proximal vasospasm. BMC Neurol. 2018;18(1):210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Robinson D, Kreitzer N, Ngwenya LB, et al. Diffusion-Weighted imaging reveals distinct patterns of cytotoxic edema in patients with subdural hematomas. J Neurotrauma. 2021;38(19):2677–2685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Major S, Petzold GC, Reiffurth C, et al. A role of the sodium pump in spreading ischemia in rats. J Cereb Blood Flow Metab. 2017;37(5):1687–1705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89. Sakowitz OW, Wolfrum S, Sarrafzadeh AS, et al. Relation of cerebral energy metabolism and extracellular nitrite and nitrate concentrations in patients after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2001;21(9):1067–1076. [DOI] [PubMed] [Google Scholar]
- 90. Fung C, Z'Graggen WJ, Jakob SM, et al. Inhaled nitric oxide treatment for aneurysmal SAH patients with delayed cerebral ischemia. Front Neurol. 2022;13:817072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91. Petzold GC, Scheibe F, Braun JS, et al. Nitric oxide modulates calcium entry through P/Q-type calcium channels and N-methyl-d-aspartate receptors in rat cortical neurons. Brain Res. 2005;1063(1):9–14. [DOI] [PubMed] [Google Scholar]
- 92. Dreier JP, Kleeberg J, Petzold G, et al. Endothelin-1 potently induces Leao's cortical spreading depression in vivo in the rat: A model for an endothelial trigger of migrainous aura? Brain. 2002;125(Pt 1):102–112. [DOI] [PubMed] [Google Scholar]
- 93. Petzold GC, Einhaupl KM, Dirnagl U, Dreier JP. Ischemia triggered by spreading neuronal activation is induced by endothelin-1 and hemoglobin in the subarachnoid space. Ann Neurol. 2003;54(5):591–598. [DOI] [PubMed] [Google Scholar]
- 94. Winkler MK, Dengler N, Hecht N, et al. Oxygen availability and spreading depolarizations provide complementary prognostic information in neuromonitoring of aneurysmal subarachnoid hemorrhage patients. J Cereb Blood Flow Metab. 2017;37(5):1841–1856. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Kawano A, Sugimoto K, Nomura S, et al. Association between spreading depolarization and delayed cerebral ischemia after subarachnoid hemorrhage: Post hoc analysis of a randomized trial of the effect of cilostazol on delayed cerebral ischemia. Neurocrit Care. 2021. [DOI] [PubMed] [Google Scholar]
- 96. Joerk A, Ritter M, Langguth N, et al. Propentdyopents as heme degradation intermediates constrict mouse cerebral arterioles and are present in the cerebrospinal fluid of patients with subarachnoid hemorrhage. Circ Res. 2019;124(12):e101–e114. [DOI] [PubMed] [Google Scholar]
- 97. Galea I, Durnford A, Glazier J, et al. Iron deposition in the brain after aneurysmal subarachnoid hemorrhage. Stroke. 2022;53(5):1633–1642. [DOI] [PubMed] [Google Scholar]
- 98. Gross BA, Du R. Vasospasm after arteriovenous malformation rupture. World Neurosurg. 2012;78(3–4):300–305. [DOI] [PubMed] [Google Scholar]
- 99. Amuluru K, Al-Mufti F, Romero CE, Gandhi CD. Isolated intraventricular hemorrhage associated with cerebral vasospasm and delayed cerebral ischemia following arteriovenous malformation rupture. Interv Neurol. 2018;7(6):479–489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Sukhotinsky I, Dilekoz E, Moskowitz MA, Ayata C. Hypoxia and hypotension transform the blood flow response to cortical spreading depression from hyperemia into hypoperfusion in the rat. J Cereb Blood Flow Metab. 2008;28(7):1369–1376. [DOI] [PubMed] [Google Scholar]
- 101. Woitzik J, Dreier JP, Hecht N, et al. Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2012;32(2):203–212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102. Vergouwen MD, Algra A, Rinkel GJ. Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis update. Stroke. 2012;43(10):2671–2676. [DOI] [PubMed] [Google Scholar]
- 103. Carrera E, Schmidt JM, Oddo M, et al. Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery. 2009;65(2):316-323; discussion 323-324. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Electronic recording, processing and storage of the data were approved by the data protection officer of the Charité—Universitätsmedizin Berlin (data protection votes from 28 May 2008 to 5 May 2014). The datasets analysed during the current study are not publicly available because the patient’s informed consent only permits the data analysis and publication by the investigators.